UCN2 and neoplasm: Tumor melanization (Figure 8—figure supplement 1d,d’) hampers proper immunolabelling and quantification of these cells, but clearly their contribution becomes very limited in tumors at later stages (Wandering L3), which are almost completely made of cells from the lymph gland (Srp positive, LacZ negative).